Regenerative Medical Technology RMTG
OTC RMTG
$0.06 +0.00 (+0.00%)
At close: Sep 28, 2026 · 4:00 PM EDT

Regenerative Medical Technology (RMTG) Total Current Liabilities (2017 - 2026)

Updated

Regenerative Medical Technology (RMTG) posted Total Current Liabilities of $42.61 million for Q2 2026, up 39.5% from $30.54 million a year earlier and up 11.5% from the prior quarter.

Analysis

Regenerative Medical Technology (RMTG) Total Current Liabilities (2017 - 2026) Analysis & Trends

At the end of FY2025, Regenerative Medical Technology's Total Current Liabilities came in at $38.13 million, up 31.6% from FY2024.

  • Annual Total Current Liabilities has increased for five consecutive years, with a five-year compound annual growth rate of 110.9% (FY2020 to FY2025).
  • In prior years, Regenerative Medical Technology's Total Current Liabilities was $28.97 million in FY2024 (+30.2%), $22.25 million in FY2023 (+85.4%), $12 million in FY2022 (+184.5%) and $4.22 million in FY2021 (+361.3%).
  • The Q2 2026 figure stands as the highest quarterly Total Current Liabilities in data going back to Q4 2017.
  • On a year-over-year basis, Total Current Liabilities has increased in each of the last three quarters, with growth averaging 17.9% over the last eight quarters.
  • The strongest year-over-year quarter for Total Current Liabilities in the past five years was Q2 2022, with growth of 363.0%; the weakest was Q3 2021, with a decline of 44.6%.
  • According to Business Quant data, Total Current Liabilities for the three prior quarters was $38.2 million (Q1 2026), $38.13 million (Q4 2025) and $17.27 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 54.90 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 41.64 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -31.55 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 3.94 Bn
10 Regenerative Medical Technology 824,338.06 -3.70 Mn 2.58 Mn 42.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 42.61 Mn
Mar 31, 2026 38.20 Mn
Dec 31, 2025 38.13 Mn
Sep 30, 2025 17.27 Mn
Jun 30, 2025 30.54 Mn
Mar 31, 2025 29.88 Mn
Dec 31, 2024 28.97 Mn
Sep 30, 2024 27.49 Mn
Jun 30, 2024 26.42 Mn
Mar 31, 2024 24.36 Mn
Dec 31, 2023 22.25 Mn
Sep 30, 2023 24.43 Mn
Jun 30, 2023 13.69 Mn
Mar 31, 2023 12.93 Mn
Dec 31, 2022 12.00 Mn
Sep 30, 2022 6.08 Mn
Jun 30, 2022 5.30 Mn
Mar 31, 2022 4.82 Mn
Dec 31, 2021 4.22 Mn
Sep 30, 2021 10.35 Mn
API Access

Regenerative Medical Technology Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=RMTG&period=max&api_key=YOUR_API_KEY